Skip to main content

Table 4 Plasma fatty acids of overweight and obese older adults in control and olive oil groups at baseline and month 3a

From: Cardio-metabolic and immunological impacts of extra virgin olive oil consumption in overweight and obese older adults: a randomized controlled trial

 

Control (N = 20)

 

Olive Oil (N = 20)

 

Fatty Acids

Baseline

Month 3

 

Baseline

Month 3

P *

   

%

   

C18:1n9 (OA)

19 ± 1

18 ± 1

 

19 ± 1

20 ± 1

0.04

Total n-3

5 ± 1

5 ± 1

 

4 ± 0.3

4 ± 0.3

0.38

Total n-6

43 ± 1

42 ± 1

 

43 ± 1

41 ± 0.3

0.31

Total PUFA

47 ± 1

47 ± 1

 

47 ± 1

45 ± 1

0.04

Total MUFA

22 ± 1

22 ± 1

 

22 ± 1

24 ± 1

0.04

Total SFA

31 ± 0.4

31 ± 1

 

31 ± 1

32 ± 1

0.47

OA/PUFA (ratio)

0.4 ± 0.02

0.4 ± 0.02

 

0.4 ± 0.02

0.5 ± 0.02

0.03

n-6/n-3 (ratio)

13 ± 1

12 ± 1

 

12 ± 1

12 ± 1

0.58

ALA

0.6 ± 0.03

0.6 ± 0.04

 

0.6 ± 0.04

0.6 ± 0.1

0.45

  1. Abbreviations: ALA alpha linolenic acid, MUFA monounsaturated fatty acids, OA oleic acid, PUFA polyunsaturated fatty acids, SFA saturated fatty acids
  2. * P-value for difference between two groups was obtained by ANCOVA adjusting for age, sex and baseline value
  3. aValues are mean ± SEM